We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$47.8B
AUM Growth
-$2.34B
(-4.7%)
Cap. Flow
-$5.56B
Cap. Flow
% of AUM
-11.64%
Top 10 Holdings %
Top 10 Hldgs %
32.03%
Holding
2,131
New
54
Increased
334
Reduced
1,616
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thomson Reuters
TRI
|
+$89.7M |
| 2 |
Fortinet
FTNT
|
+$69.3M |
| 3 |
Flowers Foods
FLO
|
+$37.9M |
| 4 |
Brown & Brown
BRO
|
+$28.6M |
| 5 |
Consolidated Edison
ED
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$626M |
| 2 |
Microsoft
MSFT
|
+$454M |
| 3 |
Apple
AAPL
|
+$414M |
| 4 |
Broadcom
AVGO
|
+$317M |
| 5 |
Amazon
AMZN
|
+$270M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Consumer Discretionary | 10.23% |
| 3 | Industrials | 9.49% |
| 4 | Communication Services | 9.26% |
| 5 | Financials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
OraSure Technologies
OSUR
$273M
| $41.3K | ﹤0.01% |
12,857
-2,562
| -17% | -$8.04K |
|
1952
Nano X Imaging
NNOX
$62.4M
| $40.7K | ﹤0.01% |
10,987
-2,190
| -17% | -$9.75K |
|
1953
SkinHealth Systems
SKIN
$94.9M
| $38.9K | ﹤0.01% |
19,552
-3,895
| -17% | -$7.91K |
|
1954
Satellogic
SATL
$532M
| $38.7K | ﹤0.01% |
11,788
-2,349
| -17% | -$8.28K |
|
1955
Quantum-Si Incorporated
QSI
$168M
| $37.9K | ﹤0.01% |
26,860
-2,064
| -7% | -$2.98K |
|
1956
Getty Images
GETY
$184M
| $37.3K | ﹤0.01% |
18,829
-3,751
| -17% | -$6.95K |
|
|
LPRO
1957
Open Lending Corp
LPRO
$373M
| $37K | ﹤0.01% |
17,530
-3,493
| -17% | -$7.89K |
|
1958
Douglas Elliman
DOUG
$155M
| $35.9K | ﹤0.01% |
12,538
-2,500
| -17% | -$6.56K |
|
1959
Larimar Therapeutics
LRMR
$416M
| $35.8K | ﹤0.01% |
11,088
+18
| +0.2% | +$67 |
|
1960
The Oncology Institute
TOI
$498M
| $35.8K | ﹤0.01% |
10,261
-1,843
| -15% | -$6.32K |
|
1961
Perspective Therapeutics
CATX
$332M
| $35K | ﹤0.01% |
10,190
-2,030
| -17% | -$7.4K |
|
1962
MaxCyte
MXCT
$116M
| $33.3K | ﹤0.01% |
21,090
-3,616
| -15% | -$6.29K |
|
1963
Heron Therapeutics
HRTX
$86.3M
| $33K | ﹤0.01% |
26,159
-5,209
| -17% | -$8.26K |
|
1964
Health Catalyst
HCAT
$154M
| $33K | ﹤0.01% |
11,564
-2,305
| -17% | -$7.89K |
|
1965
Stereotaxis
STXS
$129M
| $32.7K | ﹤0.01% |
10,506
-1,237
| -11% | -$3.2K |
|
|
EB
1966
DELISTED
Eventbrite
EB
| $32.6K | ﹤0.01% |
12,933
-2,335
| -15% | -$6.1K |
|
1967
OmniAb
OABI
$294M
| $32.6K | ﹤0.01% |
20,363
-4,775
| -19% | -$8.72K |
|
1968
Holley
HLLY
$314M
| $32K | ﹤0.01% |
10,184
-2,028
| -17% | -$6.04K |
|
|
OLPX
1969
DELISTED
Olaplex Holdings
OLPX
| $31.5K | ﹤0.01% |
24,025
-4,787
| -17% | -$6.86K |
|
1970
W&T Offshore
WTI
$545M
| $30.9K | ﹤0.01% |
16,975
-3,381
| -17% | -$6K |
|
1971
Coherus Oncology
CHRS
$217M
| $29.7K | ﹤0.01% |
18,135
-3,613
| -17% | -$4.02K |
|
1972
Accuray
ARAY
$28.4M
| $29K | ﹤0.01% |
17,341
-3,457
| -17% | -$5.11K |
|
1973
Fate Therapeutics
FATE
$281M
| $28.6K | ﹤0.01% |
22,703
-3,937
| -15% | -$4.25K |
|
1974
Aclaris Therapeutics
ACRS
$730M
| $28.2K | ﹤0.01% |
14,819
-3,794
| -20% | -$6.61K |
|
1975
SELLAS Life Sciences
SLS
$2.23B
| $27.7K | ﹤0.01% |
17,221
-2,350
| -12% | -$4.19K |
|
Similar funds
ProShare Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, ProShare Advisors held 2,131 positions worth $47.8B, down 4.7% from $50.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors withdrew a net $5.56B in Q3 2025, closing 126 positions and reducing 1,616 holdings. Its most notable exit was Ansys, an estimated $48.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, ProShare Advisors opened a new position in Thomson Reuters worth $75.8M.
- ProShare Advisors's largest Q3 2025 buy was Thomson Reuters: 480,707 shares worth $75.8M.
- ProShare Advisors added most to Fortinet in Q3 2025, an estimated $69.3M increase.
- ProShare Advisors's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $626M.
- ProShare Advisors fully exited Ansys in Q3 2025, selling an estimated $48.7M.
- ProShare Advisors's ten largest holdings make up 32% of its $47.8B portfolio in Q3 2025.
- ProShare Advisors opened 54 new positions and closed 126 in Q3 2025.
- ProShare Advisors's portfolio value fell 4.7% quarter-over-quarter to $47.8B.
Based on ProShare Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.